Shenzhen Accounts Payable from 2010 to 2024

300124 Stock   59.39  0.69  1.15%   
Shenzhen Inovance's Accounts Payable is increasing over the years with slightly volatile fluctuation. Overall, Accounts Payable is expected to go to about 12.9 B this year. Accounts Payable is the amount Shenzhen Inovance Tech owes to suppliers or vendors for products or services received but not yet paid for. It represents Shenzhen Inovance's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2007-12-31
Previous Quarter
13.6 B
Current Value
15 B
Quarterly Volatility
3.9 B
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Shenzhen Inovance financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shenzhen Inovance's main balance sheet or income statement drivers, such as Interest Expense of 187.3 M, Selling General Administrative of 2.4 B or Total Revenue of 31.9 B, as well as many indicators such as . Shenzhen financial statements analysis is a perfect complement when working with Shenzhen Inovance Valuation or Volatility modules.
  
This module can also supplement various Shenzhen Inovance Technical models . Check out the analysis of Shenzhen Inovance Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Shenzhen Stock

Shenzhen Inovance financial ratios help investors to determine whether Shenzhen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shenzhen with respect to the benefits of owning Shenzhen Inovance security.